Global Age Related Macular Degeneration (AMD) Market Insights, Forecast to 2029

Publication ID:

PB504239431

Publication Date:

May 31, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Market Analysis and Insights: Global Age Related Macular Degeneration (AMD) Market
The global Age Related Macular Degeneration (AMD) market is projected to grow from US$ 1377.7 million in 2023 to US$ 1815.4 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
Report Includes
This report presents an overview of global market for Age Related Macular Degeneration (AMD) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Age Related Macular Degeneration (AMD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Age Related Macular Degeneration (AMD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Age Related Macular Degeneration (AMD) revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Age Related Macular Degeneration (AMD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Age Related Macular Degeneration (AMD) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer, F. HoffmannLa Roche, Regeneron, Novartis, Valeant and Pfizer, etc.
By Company
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Segment by Type
Wet AMD
Dry AMD
Segment by Application
Men
Woman
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Age Related Macular Degeneration (AMD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age Related Macular Degeneration (AMD) companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Age Related Macular Degeneration (AMD) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Men
1.3.3 Woman
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Age Related Macular Degeneration (AMD) Market Perspective (2018-2029)
2.2 Global Age Related Macular Degeneration (AMD) Growth Trends by Region
2.2.1 Age Related Macular Degeneration (AMD) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Age Related Macular Degeneration (AMD) Historic Market Size by Region (2018-2023)
2.2.3 Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2024-2029)
2.3 Age Related Macular Degeneration (AMD) Market Dynamics
2.3.1 Age Related Macular Degeneration (AMD) Industry Trends
2.3.2 Age Related Macular Degeneration (AMD) Market Drivers
2.3.3 Age Related Macular Degeneration (AMD) Market Challenges
2.3.4 Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Age Related Macular Degeneration (AMD) by Players
3.1.1 Global Age Related Macular Degeneration (AMD) Revenue by Players (2018-2023)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2018-2023)
3.2 Global Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Age Related Macular Degeneration (AMD), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio
3.4.1 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration (AMD) Revenue in 2022
3.5 Global Key Players of Age Related Macular Degeneration (AMD) Head office and Area Served
3.6 Global Key Players of Age Related Macular Degeneration (AMD), Product and Application
3.7 Global Key Players of Age Related Macular Degeneration (AMD), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Age Related Macular Degeneration (AMD) Breakdown Data by Type
4.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2018-2023)
4.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2024-2029)
5 Age Related Macular Degeneration (AMD) Breakdown Data by Application
5.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2018-2023)
5.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Age Related Macular Degeneration (AMD) Market Size (2018-2029)
6.2 North America Age Related Macular Degeneration (AMD) Market Size by Type
6.2.1 North America Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023)
6.2.2 North America Age Related Macular Degeneration (AMD) Market Size by Type (2024-2029)
6.2.3 North America Age Related Macular Degeneration (AMD) Market Share by Type (2018-2029)
6.3 North America Age Related Macular Degeneration (AMD) Market Size by Application
6.3.1 North America Age Related Macular Degeneration (AMD) Market Size by Application (2018-2023)
6.3.2 North America Age Related Macular Degeneration (AMD) Market Size by Application (2024-2029)
6.3.3 North America Age Related Macular Degeneration (AMD) Market Share by Application (2018-2029)
6.4 North America Age Related Macular Degeneration (AMD) Market Size by Country
6.4.1 North America Age Related Macular Degeneration (AMD) Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
6.4.3 North America Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration (AMD) Market Size (2018-2029)
7.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type
7.2.1 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023)
7.2.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2024-2029)
7.2.3 Europe Age Related Macular Degeneration (AMD) Market Share by Type (2018-2029)
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Application
7.3.1 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2018-2023)
7.3.2 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2024-2029)
7.3.3 Europe Age Related Macular Degeneration (AMD) Market Share by Application (2018-2029)
7.4 Europe Age Related Macular Degeneration (AMD) Market Size by Country
7.4.1 Europe Age Related Macular Degeneration (AMD) Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
7.4.3 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Age Related Macular Degeneration (AMD) Market Size (2018-2029)
8.2 China Age Related Macular Degeneration (AMD) Market Size by Type
8.2.1 China Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023)
8.2.2 China Age Related Macular Degeneration (AMD) Market Size by Type (2024-2029)
8.2.3 China Age Related Macular Degeneration (AMD) Market Share by Type (2018-2029)
8.3 China Age Related Macular Degeneration (AMD) Market Size by Application
8.3.1 China Age Related Macular Degeneration (AMD) Market Size by Application (2018-2023)
8.3.2 China Age Related Macular Degeneration (AMD) Market Size by Application (2024-2029)
8.3.3 China Age Related Macular Degeneration (AMD) Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Age Related Macular Degeneration (AMD) Market Size (2018-2029)
9.2 Asia Age Related Macular Degeneration (AMD) Market Size by Type
9.2.1 Asia Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023)
9.2.2 Asia Age Related Macular Degeneration (AMD) Market Size by Type (2024-2029)
9.2.3 Asia Age Related Macular Degeneration (AMD) Market Share by Type (2018-2029)
9.3 Asia Age Related Macular Degeneration (AMD) Market Size by Application
9.3.1 Asia Age Related Macular Degeneration (AMD) Market Size by Application (2018-2023)
9.3.2 Asia Age Related Macular Degeneration (AMD) Market Size by Application (2024-2029)
9.3.3 Asia Age Related Macular Degeneration (AMD) Market Share by Application (2018-2029)
9.4 Asia Age Related Macular Degeneration (AMD) Market Size by Region
9.4.1 Asia Age Related Macular Degeneration (AMD) Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Age Related Macular Degeneration (AMD) Market Size by Region (2018-2023)
9.4.3 Asia Age Related Macular Degeneration (AMD) Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Age Related Macular Degeneration (AMD) Introduction
11.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.1.5 Bayer Recent Developments
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Details
11.2.2 F. HoffmannLa Roche Business Overview
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Introduction
11.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.2.5 F. HoffmannLa Roche Recent Developments
11.3 Regeneron
11.3.1 Regeneron Company Details
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Introduction
11.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.3.5 Regeneron Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Age Related Macular Degeneration (AMD) Introduction
11.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Valeant
11.5.1 Valeant Company Details
11.5.2 Valeant Business Overview
11.5.3 Valeant Age Related Macular Degeneration (AMD) Introduction
11.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.5.5 Valeant Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Introduction
11.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.6.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂